Why the study?
Preload reduction for decongestion in decompensated heart failure is typically limited to diuretics and hemofiltration, while several new technologies to mechanically reduce cardiac preload are in development.
Does mechanical preload reduction improve decongestion, cardiac filling pressures, and clinical outcomes in patients with decompensated heart failure?
Does mechanical preload reduction improve decongestion, cardiac filling pressures, and clinical outcomes in patients with decompensated heart failure?
This review highlights the pathophysiology of excess preload and diuretic resistance in decompensated heart failure while summarizing early clinical evidence for emerging mechanical preload reduction devices targeting the superior and inferior vena cava.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for mechanical preload reduction in decompensated HF; prospective trials needed before clinical adoption.
Decongestion is a cornerstone therapeutic goal for those presenting with decompensated heart failure. Current approaches to clinical decongestion include reducing cardiac preload, which is typically limited to diuretics and hemofiltration. Several new technologies designed to mechanically reduce cardiac preload are in development. In this review, we discuss the pathophysiology of decompensated heart failure; the central role of targeting cardiac preload; emerging mechanical preload reduction technologies; and potential application of these devices.
No takes yet. Share an insight, caveat, or question.
Kapur et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: